NCT00524186View on ClinicalTrials.gov

Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

August 31, 2013

Study Completion Date

April 30, 2016

Conditions

Esophageal CancerGastric Cancer

Interventions

DRUG

fluorouracil

Given IV

DRUG

irinotecan hydrochloride

Given IV

DRUG

leucovorin calcium

Given IV

DRUG

sunitinib malate

Taken Orally

OTHER

flow cytometry

Correlative Study

OTHER

pharmacological study

Correlative Study

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Roswell Park Cancer Institute

OTHER